Vanguard Personalized Indexing Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.8K	Buy	13,988 +1,110	+9%	+$3.99K	﹤0.01%	2057
2025 Q4	$44K	Buy	12,878 +176	+1%	+$786	﹤0.01%	1896
2025 Q3	$63.9K	Buy	12,702 +234	+2%	+$1.03K	﹤0.01%	1880
2025 Q2	$42.8K	Buy	12,468 +1,146	+10%	+$2.85K	﹤0.01%	1848
2025 Q1	$25.2K	Sell	11,322 -11,055	-49%	-$31.7K	﹤0.01%	1749
2024 Q4	$65.6K	Buy	22,377 +7,426	+50%	+$20.7K	﹤0.01%	1667
2024 Q3	$38.9K	Buy	14,951 +1,024	+7%	+$2.84K	﹤0.01%	1700
2024 Q2	$41.2K	Buy	13,927 +621	+5%	+$2.35K	﹤0.01%	1602
2024 Q1	$60.3K	Sell	13,306 -953	-7%	-$4.86K	﹤0.01%	1556
2023 Q4	$81.4K	Buy	+14,259	New	+$66.1K	﹤0.01%	1490